Laparoscopic Sentinel Lymph Node Localization in Operable Cervix Cancer

This study has been completed.
Sponsor:
Information provided by:
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT00205010
First received: September 13, 2005
Last updated: June 10, 2008
Last verified: June 2008
  Purpose

The purpose of this study is to evaluate the feasibility, safety and efficacy of laparoscopic ovarian transposition in women less than 40 years of age with locally advanced cervical squamous cell carcinoma


Condition Intervention Phase
Cervical Cancer
Procedure: Lymphoscintigraphy
Phase 1

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Laparoscopic Sentinel Lymph Node Localization in Patients With Operable Cervical Cancer - A Pilot Study

Resource links provided by NLM:


Further study details as provided by University of Wisconsin, Madison:

Enrollment: 20
Study Start Date: October 2003
Study Completion Date: June 2006
Primary Completion Date: February 2006 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Stage IAI to IIA cervix cancer undergoing primary surgical management

Exclusion Criteria:

  • Previous pelvic dissection
  • Previous para-aortic lymph node dissection
  • Evidence of distant mets
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00205010

Locations
United States, Wisconsin
University of Wisconsin
Madison, Wisconsin, United States, 53792
Sponsors and Collaborators
University of Wisconsin, Madison
Investigators
Principal Investigator: David M Kushner, MD University of Wisconsin, Madison
  More Information

No publications provided by University of Wisconsin, Madison

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00205010     History of Changes
Other Study ID Numbers: CO 03701, H-2003-0442
Study First Received: September 13, 2005
Last Updated: June 10, 2008
Health Authority: United States: Food and Drug Administration

Additional relevant MeSH terms:
Uterine Cervical Neoplasms
Uterine Neoplasms
Genital Neoplasms, Female
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Uterine Cervical Diseases
Uterine Diseases
Genital Diseases, Female

ClinicalTrials.gov processed this record on September 22, 2014